Vitaspring Biomedical VSBC
OTC VSBC
$0.02 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Vitaspring Biomedical (VSBC) Long-Term Investments (2022)

Updated

Vitaspring Biomedical (VSBC) recorded Long-Term Investments of $283,730 in fiscal Q3 2023 (quarter ended Oct 31, 2022), unchanged from the prior quarter.

Analysis

Vitaspring Biomedical (VSBC) Long-Term Investments (2022) Analysis & Trends

At the end of FY2022 (ended Jan 31, 2022), Vitaspring Biomedical reported Long-Term Investments of $282,469.

  • Quarterly Long-Term Investments has ranged from $282,469 in fiscal Q4 2022 to $419,554 in fiscal Q1 2023 over the past five years.
  • Per Business Quant, the preceding three fiscal quarters came in at $283,729 (Q2 2023), $419,554 (Q1 2023) and $282,469 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Vitaspring Biomedical 4.14 Mn 4.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2022 283,730.00
Jul 31, 2022 283,729.00
Apr 30, 2022 419,554.00
Jan 31, 2022 282,469.00
API Access

Vitaspring Biomedical Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=VSBC&period=max&api_key=YOUR_API_KEY